Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Ofer Merimsky
41 années d'expérience
accréditations :
La clinique est certifiée :
Pourquoi choisir Israël pour la thérapie biologique ?
Accédez à des solutions avancées de thérapie biologique dans des cliniques de confiance .
| Israël | Turquie | Espagne | |
| Thérapie biologique | - | de $5,500 | de $15,000 |
Jour 1 - Arrivée
Jour 2 - Pré-opération
Jour 3 - Préparation à la thérapie biologique
Jour 4 - Thérapie biologique
Jour 5 - Post-opératoire
Semaine 1 - Rééducation
Semaine 2 - Rééducation
Semaine 4 - Rééducation
Veuillez noter que le calendrier et le processus peuvent varier en fonction des problèmes de santé individuels et de la réponse à la thérapie.
Le Dr Sarid est spécialisé en thérapie biologique du cancer au Centre médical Sourasky, avec plus de 15 ans d'expérience en oncologie.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
Le Dr Ari Raphael dirige des recherches génomiques révolutionnaires au Sourasky Medical Center, spécialisé dans la thérapie biologique pour les malignités thoraciques.